FindTrial
Sign In

Evaluation of safety and efficacy of total arch replacement combined with right vagal subclavian artery reconstruction

Evaluation of safety and efficacy of total arch replacement combined with right vagal subclavian artery reconstruction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093655
Enrollment
Unknown
Registered
2024-12-10
Start date
2024-12-15
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic dissection with aberration of the right subclavian artery

Interventions

Right vagal subclavian artery reconstruction group:NA

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1). Age 18 years or older, 2) Patients with aortic dissection undergoing total arch replacement combined with right vagal subclavian artery reconstruction surgery, 3) Patients with no previous history of thoracic surgery

Exclusion criteria

Exclusion criteria: 1). Patients with severe peripheral vascular disease or mutation, 2). Patients with malignant tumors, 3) Patients with thoracic malformations

Design outcomes

Primary

MeasureTime frame
Overall survival rate;Intraoperative extracorporeal circulation time;Blood loss;Postoperative complications;;Quality of life;—

Countries

China

Contacts

Public ContactLian Li

West China Hospital of Sichuan University

liliandyx@163.com+86 132 8115 1891

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026